FDA Alignment -- BioAtla ( BCAB 4.08%) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints ...
And good afternoon, and welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2025 Conference Call. 2025 is ...
Presented new subgroup analyses from phase 3 clinical trial of CAN-2409 in localized prostate cancer at the American Society ...
Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsDavid Dodd - Chairman, President & CEOMark Reynolds ...
Hello, and thank you for joining us for i-80 Gold's 2025 Third Quarter Conference Call and Webcast. Today's company presenters include Richard Young, President and Chief Executive Officer of i-80 Gold ...
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused ...
Posifa Technologies has announced the PMF82000 series of mass air flow sensors, designed to measure low air flow rates with ...
1. Spend some time reflecting on values so that you can use them to guide your behavior. Controlling responses is easier when ...
In this moment, we're building the steam engine for this new natural resource—data. We must ensure that we build it not only ...
In industrial and industrial IoT (IIoT) applications, PMICs address key power challenges such as high efficiency, robustness, ...
The immune system faces a delicate balancing act: it must be aggressive enough to fight infections and cancer, yet restrained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback